Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizia Mello Grand

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Experimental and Therapeutic Medicine|September 21, 2012
Absence of the K303R estrogen receptor α mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatmentChiara Ghimenti, Maurizia Mello-Grand, Lea Regolo, et al.
Experimental and Therapeutic Medicine|February 15, 2013
Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapyChiara Ghimenti, Maurizia Mello-Grand, Enrico Grosso, et al.
Molecular Medicine (Cambridge, Mass.)|December 4, 2009
CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cellsSilvia Deaglio, Semra Aydin, Maurizia Mello Grand, et al.
Oncotarget|July 8, 2016
Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancerKarine Lefort, Paola Ostano, Maurizia Mello-Grand, et al.
International Journal of Cancer|October 2, 2009
Altered molecular pathways in melanocytic lesionsMaria Scatolini, Maurizia Mello Grand, Enrico Grosso, et al.
International Journal of Molecular Sciences|February 12, 2020
Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate AdenocarcinomaPaola Ostano, Maurizia Mello-Grand, Debora Sesia, et al.
Antiviral Research|October 18, 2023
Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replicationAnna Luganini, Giulia Sibille, Marta Pavan, et al.
Plos One|May 19, 2010
ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancerPaolo Kunderfranco, Maurizia Mello-Grand, Romina Cangemi, et al.
BMC Cancer|January 27, 2011
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancerCaterina Peraldo-Neia, Giorgia Migliardi, Maurizia Mello-Grand, et al.
Plos One|October 3, 2012
Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissuesMaurizio Callari, Matteo Dugo, Valeria Musella, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Experimental and Therapeutic Medicine|September 21, 2012
Absence of the K303R estrogen receptor α mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatmentChiara Ghimenti, Maurizia Mello-Grand, Lea Regolo, et al.
Experimental and Therapeutic Medicine|February 15, 2013
Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapyChiara Ghimenti, Maurizia Mello-Grand, Enrico Grosso, et al.
Molecular Medicine (Cambridge, Mass.)|December 4, 2009
CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cellsSilvia Deaglio, Semra Aydin, Maurizia Mello Grand, et al.
Oncotarget|July 8, 2016
Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancerKarine Lefort, Paola Ostano, Maurizia Mello-Grand, et al.
International Journal of Cancer|October 2, 2009
Altered molecular pathways in melanocytic lesionsMaria Scatolini, Maurizia Mello Grand, Enrico Grosso, et al.
International Journal of Molecular Sciences|February 12, 2020
Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate AdenocarcinomaPaola Ostano, Maurizia Mello-Grand, Debora Sesia, et al.
Antiviral Research|October 18, 2023
Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replicationAnna Luganini, Giulia Sibille, Marta Pavan, et al.
Plos One|May 19, 2010
ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancerPaolo Kunderfranco, Maurizia Mello-Grand, Romina Cangemi, et al.
BMC Cancer|January 27, 2011
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancerCaterina Peraldo-Neia, Giorgia Migliardi, Maurizia Mello-Grand, et al.
Plos One|October 3, 2012
Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissuesMaurizio Callari, Matteo Dugo, Valeria Musella, et al.
Pageof 4